ArticleDermatology and therapy2022

Long-Term Benefit-Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis.

April W Armstrong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.